Open in app

Sign in

Write

Sign in

When new pharmaceutical companies enter this market, they will have to offer patients lower prices than Eli Lilly and Novo Nordisk in order to gain market share. This is the most likely medium-term solution to drive down the costs of GLP-1 drugs and eliminate t…

Wannabe Weight Loss Drugs Pack Serious Undisclosed Risks
1.3K
21

The Conversation U.S.

--

--

Michelle Teheux
Michelle Teheux

Written by Michelle Teheux

15.9K Followers
868 Following

Lover of literature. Former newspaper editor. Fascinated by everything. Contact: michelleteheux@gmail.com. To buy me a coffee: https://ko-fi.com/michelleteheux

No responses yet

Help

Status

About

Careers

Press

Blog

Privacy

Terms

Text to speech

Teams